These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SCHEDULE 14A
|
|
NMI Holdings, Inc.
|
|
1)
|
Title of each class of securities to which transaction applies:
|
|
|
2)
|
Aggregate number of securities to which transaction applies:
|
|
|
3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
4)
|
Proposed maximum aggregate value of transaction:
|
|
|
5)
|
Total fee paid:
|
|
|
1)
|
Amount previously paid:
|
|
|
2)
|
Form, Schedule, or Registration Statement No.:
|
|
|
3)
|
Date Filed:
|
|
|
1.
|
the election of seven directors to the board of directors to serve until the 2016 Annual Meeting of Stockholders;
|
|
2.
|
the ratification of the appointment of BDO USA, LLP as NMI's independent registered public accounting firm for the year ending December 31, 2015; and
|
|
3.
|
any other matters that properly come before the Annual Meeting.
|
|
ABOUT THE ANNUAL MEETING AND PROXY STATEMENT
|
|
|
ITEM 1 - ELECTION OF DIRECTORS
|
|
|
CORPORATE GOVERNANCE AND BOARD MATTERS
|
|
|
EXECUTIVE OFFICERS
|
|
|
COMPENSATION OF NAMED EXECUTIVE OFFICERS AND DIRECTORS
|
|
|
BENEFICIAL OWNERSHIP OF COMMON STOCK
|
|
|
ITEM 2 - RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
|
|
|
FORM OF PROXY CARD
|
|
|
•
|
possess fundamental qualities of intelligence, honesty, perceptiveness, good judgment, maturity, high ethics and standards, integrity, fairness and responsibility;
|
|
•
|
maintain a genuine interest in the Company and the recognition that as a member of the Board he or she is accountable to the stockholders of the Company and not to any particular interest group;
|
|
•
|
have financial services industry experience gained through senior management or board of director service;
|
|
•
|
have prior board experience, either as a director of a public company or as both an executive officer of a public company and a director of a privately held company;
|
|
•
|
not serve on more than three other boards of directors of companies;
|
|
•
|
meet the independence requirements under NASDAQ listing requirements (other than our management directors);
|
|
•
|
have the ability and be willing to spend the time required to function effectively as a director;
|
|
•
|
be compatible and able to work well with other directors and executives in a team effort with a view to a long-term relationship with the Company as a director; and
|
|
•
|
possess independent opinions and be willing to express them in a constructive manner.
|
|
•
|
acting as the primary contact between the Company and the independent directors, undertaking to meet or confer periodically with members of the Company's executive team regarding matters related to the business of the Company;
|
|
•
|
assisting the Chairman of the Board, as necessary with conducting Board meetings;
|
|
•
|
preparing agenda items for meetings of the Board and any committees thereof; and
|
|
•
|
such other duties as the Board may from time to time assign to the Lead Director.
|
|
•
|
the integrity of the financial statements of the Company;
|
|
•
|
the independent auditor's qualifications and independence;
|
|
•
|
the performance of the Company's internal audit function and independent auditors;
|
|
•
|
the Company's system of disclosure controls and system of internal controls over financial reporting; and
|
|
•
|
the Company's compliance with legal and regulatory requirements.
|
|
•
|
overseeing our executive compensation program, including approving corporate goals relating to compensation for our Chief Executive Officer and other senior executives and determining the annual compensation of our Chief Executive Officer and other senior executives;
|
|
•
|
reviewing and approving the compensation policy recommended by management with respect to other employees;
|
|
•
|
determining, subject to ratification by our independent directors, the compensation of our independent directors;
|
|
•
|
evaluating the relationship between our risk management practices and our compensation policies and practices applicable to all employees, including our Chief Executive Officer, to consider whether they encourage risk-taking that would be reasonably likely to have a material adverse effect on the Company;
|
|
•
|
reviewing and approving incentive and equity-based compensation plans and grants; and
|
|
•
|
preparing the Compensation Committee Report and reviewing any Compensation Discussion and Analysis included in our proxy statement, to the extent such disclosure is required by SEC rules. These rules are not yet applicable to us because we currently qualify as an emerging growth company under the Jumpstart Our Business Startups Act.
|
|
•
|
identifying individuals qualified to become Board members, and recommending to the Board nominees for election for the next annual meeting of stockholders;
|
|
•
|
reviewing the qualifications and independence of the members of the Board and its committees on a regular periodic basis;
|
|
•
|
recommending to the Board corporate governance guidelines and reviewing such guidelines, as well as the Governance and Nominating Committee charter to confirm that they remain consistent with sound corporate governance practices and with any legal requirements;
|
|
•
|
leading the Board in its annual review of the Board's and its Committees' performance; and
|
|
•
|
recommending committee assignments for members of the Board.
|
|
•
|
monitoring the performance of the Company's insured books of business and the principal factors affecting performance;
|
|
•
|
discussing, reviewing and monitoring the Company's mortgage insurance products, including premium rates, underwriting guidelines and returns;
|
|
•
|
reviewing and approving the Company's investment policy and reviewing the performance of the investment portfolio;
|
|
•
|
reviewing the mortgage insurance operating environment, including the state of local and regional housing markets, competitive forces affecting the Company and the Company's relationships with residential mortgage lenders and investors; and
|
|
•
|
assisting the Board in its oversight of the Company's enterprise risk management approach, including the significant risk management policies, procedures and processes.
|
|
•
|
The Audit Committee oversees and reviews risks associated with financial accounting and reporting, including our system of internal controls, as well as fraud risk, information technology and cybersecurity risk, and major legislative and regulatory developments which could result in material financial risk exposures. In performing this function, the Audit Committee considers information from our independent registered public accounting firm and internal auditors and discusses relevant issues with management and the independent registered public accounting firm. The Audit Committee also reviews any proposed related person transactions to ensure that we do not engage in transactions that would create or otherwise give the impression of a conflict of interest that could result in harm to us.
|
|
•
|
The Compensation Committee evaluates the risks and rewards associated with our compensation philosophy and programs.
|
|
•
|
The Governance and Nominating Committee oversees our implementation of sound corporate governance principles and practices. In performing this function, the Governance and Nominating Committee periodically reviews and recommends changes to the Company's Corporate Governance Guidelines and recommends any additional actions related to governance matters that it may deem necessary or advisable from time to time.
|
|
•
|
The Risk Committee assists the Board in its oversight and review of information regarding our enterprise risk management approach and oversees risks related to our mortgage insurance business and investment portfolio.
|
|
Name and Principal Position
|
Year
|
NMI Pre-Capitalization Consulting Fee
(1)
|
Salary
|
Bonus
(2)
|
Stock Awards
(3)
|
Option Awards
(4)
|
Non-Equity Incentive Plan Compensation
|
All Other Compensation
(5)
|
Total
|
|
Bradley M. Shuster, Chief Executive Officer
|
2014
|
$—
|
$600,000
|
$600,000
|
$251,328
|
$753,949
|
$—
|
$55,429
|
$2,260,706
|
|
2013
|
$—
|
$585,000
|
$1,458,000
|
$883,350
|
$607,998
|
$—
|
$25,600
|
$3,559,948
|
|
|
2012
|
$226,323
|
$163,692
|
$452,623
|
$5,041,575
|
$3,521,100
|
$—
|
$—
|
$9,405,313
|
|
|
John (Jay) M. Sherwood, Jr., President
|
2014
|
$—
|
$400,000
|
$400,000
|
$113,344
|
$339,948
|
$—
|
$52,800
|
$1,306,092
|
|
2013
|
$—
|
$393,333
|
$972,000
|
$418,175
|
$270,221
|
$—
|
$25,600
|
$2,079,329
|
|
|
2012
|
$226,323
|
$163,692
|
$301,749
|
$2,520,788
|
$1,760,550
|
$—
|
$—
|
$4,973,102
|
|
|
Claudia J. Merkle, Chief of Insurance Operations
|
2014
|
$—
|
$350,000
|
$267,750
|
$117,040
|
$377,720
|
$—
|
$41,300
|
$1,153,810
|
|
(1)
|
Mr. Shuster and Mr. Sherwood were paid as consultants to the Company prior to its capitalization in April 2012. These amounts represent consulting fees earned during 2011 and 2012, which were paid in 2012 upon capitalization.
|
|
(2)
|
For each of Mr. Shuster and Mr. Sherwood, the 2013 bonus amount includes (i) a GSE Approval bonus, (ii) a bonus for filing a registration statement and (iii) a bonus for the effectiveness of the registration statement. These bonus opportunities were provided for under Messrs. Shuster and Sherwood's respective employment agreements. Each bonus was $300,000 for Mr. Shuster and $200,000 for Mr. Sherwood (for a total of $900,000 and $600,000, respectively) and paid in 2013. The 2013 bonus amount also includes each named executive officer's 2013 annual incentive bonus that was earned in 2013 but paid in 2014. The 2014 bonus amount includes each named executive officer's 2014 annual incentive bonus that was earned in 2014 but paid in 2015.
|
|
(3)
|
Represents the grant date fair value of the restricted stock units ("RSUs") granted to our named executive officers in the respective fiscal year, calculated in accordance with FASB ASC Topic 718, Compensation-Stock Compensation ("ASC Topic 718").
|
|
(4)
|
Represents the grant date fair value of stock options granted to our named executive officers in the respective fiscal year, calculated in accordance with ASC Topic 718. See Note 7, "Share-Based Compensation" of our consolidated financial statements filed with the SEC on Form 10-K for the fiscal year ended December 31, 2014 for an explanation of the assumptions made in valuing these awards.
|
|
(5)
|
Amounts shown represent payments made to each of the named executive officers that were intended to allow the named executive officers to avail themselves of a range of market competitive perquisites, such as auto leasing, financial planning, tax preparation, estate planning, health assessments, club memberships, spousal travel in connection with business events and parking. The amounts in this column also include Company matching contributions under the Company's 401(k) plan, as discussed below in "
Other Compensation Programs and Practices - Retirement Plans and Other Benefit Plans
." The amounts in this column for Mr. Sherwood also include an annual Company contribution to his health savings account, a tax-advantaged medical savings account, which is an annual benefit available under the medical benefit plans we offer to all of the Company's eligible employees, including our named executive officers.
|
|
Name
|
Grant Date
|
All Other Stock Awards: Number of Shares of Stock or Units (#)
(1)
|
All Other Option Awards: Number of Securities Underlying Options
(2)
|
Exercise or Base price of Option Awards ($/Sh)
|
Grant Date Fair Value of Stock and Option Awards
(3)
|
|
Bradley M. Shuster
|
2/12/2014
|
—
|
151,700
|
$12.32
|
$753,949
|
|
2/12/2014
|
20,400
|
—
|
$—
|
$251,328
|
|
|
John (Jay) M. Sherwood, Jr.
|
2/12/2014
|
—
|
68,400
|
$12.32
|
$339,948
|
|
2/12/2014
|
9,200
|
—
|
$—
|
$113,344
|
|
|
Claudia J. Merkle
|
2/12/2014
|
—
|
76,000
|
$12.32
|
$377,720
|
|
2/12/2014
|
9,500
|
—
|
$—
|
$117,040
|
|
|
(1)
|
The 2014 RSU grants vest in 1/3 increments on the first, second and third anniversaries of the grant date.
|
|
(2)
|
The 2014 stock option grants vest in 1/3 increments on the first, second, and third anniversaries of the grant date.
|
|
(3)
|
The amounts included in this column reflect the grant date fair value of stock option and RSU awards to our named executive officers in 2014. The grant date fair value was determined in accordance with ASC Topic 718.
|
|
|
|
Option Awards
|
Stock Awards
|
|||||||
|
Name
|
Grant Year
|
Number of Securities Underlying Unexercised Options Exercisable (#)
|
Number of Securities Underlying Unexercised Options Unexercisable (#)
|
Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (#)
|
Option Exercise Price ($)
|
Option Expiration Date
|
Number of Shares or Units of Stock That Have Not Vested (#)
|
Market Value of Shares or Units of Stock That Have Not Vested ($)
|
Equity
Incentive
Plan Awards:
Number of
Unearned
Shares, Units or
Other Rights
That Have Not
Vested (#)
|
Equity
Incentive
Plan Awards:
Market or
Payout Value
of Unearned
Shares, Units or
Other Rights
That Have Not
Vested ($)
(9)
|
|
Bradley M. Shuster
|
2012
|
605,000
|
302,500
(1)
|
—
|
$10.00
|
4/24/2022
|
—
|
—
|
453,750
(6)
|
$4,142,738
|
|
2013
|
44,445
|
88,888
(2)
|
—
|
$11.75
|
2/14/2023
|
—
|
—
|
24,000
(7)
|
$219,120
|
|
|
2014
|
—
|
151,700
(3)
|
—
|
$12.32
|
2/12/2024
|
—
|
—
|
20,400
(8)
|
$186,252
|
|
|
John (Jay) M. Sherwood, Jr.
|
2012
|
302,500
|
151,250
(1)
|
—
|
$10.00
|
4/24/2022
|
—
|
—
|
226,875
(6)
|
$2,071,369
|
|
2013
|
19,753
|
39,506
(2)
|
—
|
$11.75
|
2/14/2023
|
—
|
—
|
10,666
(7)
|
$97,381
|
|
|
2014
|
—
|
68,400
(3)
|
—
|
$12.32
|
2/12/2024
|
—
|
—
|
9,200
(8)
|
$83,996
|
|
|
Claudia J. Merkle
|
2012
|
8,000
|
4,000
(4)
|
—
|
$10.00
|
5/30/2022
|
—
|
—
|
—
|
$—
|
|
2012
|
8,000
|
4,000
(5)
|
—
|
$10.00
|
11/7/2022
|
—
|
—
|
6,111
(6)
|
$55,794
|
|
|
2013
|
10,083
|
20,164
(2)
|
—
|
$11.75
|
2/14/2023
|
—
|
—
|
—
|
$—
|
|
|
2014
|
—
|
76,000
(3)
|
—
|
$12.32
|
2/12/2024
|
—
|
—
|
9,500
(8)
|
$86,735
|
|
|
(1)
|
Remaining stock options vest 100% on 4/24/2015.
|
|
(2)
|
Remaining stock options vest 50% on 2/14/2015 and 50% on 2/14/2016.
|
|
(3)
|
Stock options vest one-third on each of 2/12/2015, 2/12/2016 and 2/12/2017.
|
|
(4)
|
Remaining stock options vest 100% on 5/30/2015.
|
|
(5)
|
Remaining stock options vest 100% on 11/7/2015.
|
|
(6)
|
The shares reported in grant year 2012 represent shares underlying RSUs that were granted in 2012 and that were outstanding as of December 31, 2014.
73%
of the shares underlying the RSUs are scheduled to vest based on the achievement of stock-price performance conditions (the "performance shares"). The performance shares are scheduled to vest in 1/2 increments in the event that the Company achieves a stock price of $14.00 and $16.00, in each case, during any 30-day trading period.
27%
of the shares underlying the RSUs reported in grant year 2012 represent shares that are time-vested and will fully vest on the third anniversary of the grant date, for Messrs. Shuster and Sherwood on 4/24/2015 and for Ms. Merkle on 11/7/2015.
|
|
(7)
|
Remaining RSUs vest 50% on 2/14/2015 and 50% on 2/14/2016.
|
|
(8)
|
RSUs vest in thirds on 2/12/2015, 2/12/2016 and 2/12/2017.
|
|
(9)
|
The payout value is based on the $9.13 closing price of our common stock on NASDAQ on December 31, 2014 multiplied by the number of unvested RSUs as of December 31, 2014.
|
|
•
|
the acquisition by any individual, entity or group of "beneficial ownership" (pursuant to the meaning given in Rule 13d-3 under the Securities Exchange Act of 1934) of 35% or more (on a fully diluted basis) of either (i) the outstanding shares of our common stock or (ii) the combined voting power of our then outstanding voting securities, with each of the foregoing subject to certain customary exceptions;
|
|
•
|
the replacement of a majority of the directors that constituted our Board as of the closing of the Private Placement by directors whose appointment or election is not endorsed by at least two- thirds of the directors on the Board as of the closing of the Private Placement, subject to certain exceptions;
|
|
•
|
approval by our stockholders of our complete dissolution or liquidation; or
|
|
•
|
a merger of the Company, the sale or disposition by the Company of all or substantially all of our assets or any other
|
|
Name
|
Scenario
|
Cash Severance ($)
|
Stock Option Vesting ($)
|
Restricted Stock Unit Vesting ($)
|
Benefits ($)
|
Total ($)
|
|
Bradley M. Shuster
|
Voluntary Resignation (no Good Reason)
|
- (1)
|
-
|
-
|
- (2)
|
-
|
|
Qualifying Termination
|
$1,200,000 (3)
|
- (4)
|
$1,535,210 (5)
|
- (2)
|
$2,735,210
|
|
|
Involuntary Termination for Cause
|
- (1)
|
-
|
-
|
- (2)
|
-
|
|
|
Qualifying Termination Following Change in Control
|
$3,600,000 (6)
|
- (7)
|
$1,535,210 (8)
|
- (2)
|
$5,135,210
|
|
|
No Termination Following Change in Control
|
-
|
- (7)
|
$1,535,210 (8)
|
-
|
$1,535,210
|
|
|
John (Jay) M. Sherwood, Jr.
|
Voluntary Resignation (no Good Reason)
|
- (1)
|
-
|
-
|
- (2)
|
-
|
|
Qualifying Termination
|
$800,000 (3)
|
- (4)
|
$746,295 (5)
|
- (2)
|
$1,546,295
|
|
|
Involuntary Termination for Cause
|
- (1)
|
-
|
-
|
- (2)
|
-
|
|
|
Qualifying Termination Following Change in Control
|
$2,400,000 (6)
|
- (7)
|
$746,295 (8)
|
- (2)
|
$3,146,295
|
|
|
No Termination Following Change in Control
|
-
|
- (7)
|
$746,295 (8)
|
-
|
$746,295
|
|
|
Claudia J. Merkle
|
Voluntary Resignation (no Good Reason)
|
-
|
-
|
-
|
-
|
-
|
|
Qualifying Termination
|
-
|
- (9)
|
-
|
-
|
-
|
|
|
Involuntary Termination for Cause
|
-
|
-
|
-
|
-
|
-
|
|
|
Qualifying Termination Following Change in Control
|
-
|
- (7)
|
$101,946 (8)
|
-
|
$101,946
|
|
|
No Termination Following Change in Control
|
-
|
- (7)
|
$101,946 (8)
|
-
|
$101,946
|
|
|
(1)
|
Under the terms of Messrs. Shuster's and Sherwood's respective employment agreements, each would be entitled to be paid his respective earned and unpaid annual base salary in effect at the time of termination and any earned and unpaid annual bonus for a prior award period (other than any deferred portion of such earned and unpaid annual bonus).
|
|
(2)
|
Under the terms of their respective employment agreements, Messrs. Shuster and Sherwood each would be entitled to be paid the amounts of any Accrued Benefits through the date of termination to the extent not previously paid or provided.
|
|
(3)
|
As provided in Messrs. Shuster's and Sherwood's respective employment agreements, amount includes the sum of (i) Mr. Shuster's or Mr. Sherwood's 2014 annual base salary plus (ii) his 2014 target annual bonus, which is 100% of the annual base salary.
|
|
(4)
|
Upon a Qualifying Termination, any outstanding stock options that were not then exercisable and vested would have become fully exercisable and vested at the date of such termination. The exercise prices of all outstanding stock options as of December 31, 2014 were in excess of the closing price of our common stock on December 31, 2014. Accordingly, no value is listed in this table in respect of accelerated stock option vesting assuming a Qualifying Termination on December 31, 2014.
|
|
(5)
|
With a Qualifying Termination, unvested time-vested shares would have become fully vested at the date of termination and unvested performance shares would have remained outstanding and subject to vesting upon the achievement of the applicable stock price goals.
|
|
(6)
|
As provided in Messrs. Shuster's and Sherwood's respective employment agreements, amount includes three times the sum of (i) Mr. Shuster's or Mr. Sherwood's 2014 annual base salary plus (ii) his 2014 target annual bonus, which is 100% of the annual base salary.
|
|
(7)
|
Upon a change in control, any outstanding stock options that were not then exercisable and vested would have become fully exercisable and vested as of the date of such change in control. The exercise prices of all outstanding stock options as of December 31, 2014 were in excess of the closing price of our common stock on December 31, 2014. Accordingly, no value is listed in this table in respect of accelerated stock option vesting assuming a change in control on December 31, 2014.
|
|
(8)
|
Upon a change in control, time-vested shares would have become fully vested and our Compensation Committee would thereafter determine whether outstanding performance shares would vest based on the attainment of the stock price goals at the time of the change in control.
|
|
(9)
|
With a Qualifying Termination, a prorated portion of Ms. Merkle's outstanding stock options that were not then exercisable and vested would have become fully exercisable and vested at the date of termination, and Ms. Merkle would have 90 days following such Qualifying Termination to exercise her vested stock options. The exercise prices of all outstanding stock options as of December 31, 2014 were in excess of the closing price of our common stock on December 31, 2014. Accordingly, no value is listed in this table in respect of accelerated stock option vesting assuming a Qualifying Termination on December 31, 2014.
|
|
|
Fees earned or paid in cash
|
Stock awards
|
Total
|
|
Name
|
($)
|
($)
(3)
|
($)
|
|
Michael Embler
(1)
|
$65,000
|
$49,993
|
$114,993
|
|
James G. Jones
(1)
|
$65,000
|
$49,993
|
$114,993
|
|
Michael Montgomery
(1)
|
$65,000
|
$49,993
|
$114,993
|
|
John Brandon Osmon
(1)
|
$65,000
|
$49,993
|
$114,993
|
|
James H. Ozanne
(2)
|
$65,000
|
$49,993
|
$114,993
|
|
Steven L. Scheid
(2)
|
$65,000
|
$49,993
|
$114,993
|
|
•
|
each person known to us to be the beneficial owner of more than five percent of our Class A common stock;
|
|
•
|
each named executive officer;
|
|
•
|
each of our directors; and
|
|
•
|
all of our current executive officers, identified above under the caption "
Executive Officers,
" and directors as a group.
|
|
|
Shares of Class A Common
Stock Beneficially Owned
|
|
|
|
Number
|
%
|
|
Named Executive Officers and Directors:
|
|
|
|
Bradley M. Shuster
(1)
|
1,584,657
|
2.7%
|
|
Jay M. Sherwood
(2)
|
918,161
|
1.6%
|
|
Claudia J. Merkle
(3)
|
65,695
|
*
|
|
John Brandon Osmon
(4)
|
5,539,769
|
9.5%
|
|
James H. Ozanne
(5)
|
148,892
|
*
|
|
Steven L. Scheid
(6)
|
156,392
|
*
|
|
Michael Embler
(7)
|
43,269
|
*
|
|
James G. Jones
(8)
|
88,269
|
*
|
|
Michael Montgomery
(9)
|
27,799
|
*
|
|
All executive officers and directors as a group (13 persons)
|
8,829,324
|
14.5%
|
|
*
|
Represents less than 1% beneficial ownership.
|
|
(1)
|
Represents 250,000 shares held in the Shuster Family Trust of which Mr. Shuster and his wife are co-trustees and beneficiaries, 81,769 vested performance shares, 82,182 vested RSUs, 744,456 vested stock options, 123,750 RSUs expected to vest within 60 days of March 26, 2015 and 302,500 stock options expected to vest within 60 days of March 26, 2015.
|
|
(2)
|
Represents 250,000 shares held in the Sherwood Revocable Trust of which Mr. Sherwood and his wife are co-trustees and beneficiaries, 42,225 vested performance shares, 48,005 vested RSUs, 364,806 vested stock options, 61,875 RSUs expected to vest within 60 days of March 26, 2015 and 151,250 stock options expected to vest within 60 days of March 26, 2015.
|
|
(3)
|
Represents 1,365 vested performance shares, 2,831 vested RSUs and 61,499 vested stock options.
|
|
(4)
|
Represents 19,422 vested RSUs, 18,907 vested stock options, 4,940 RSUs expected to vest within 60 days of March 26, 2015, and (i) 5,324,300 shares held by Hayman Capital Master Fund, LP ("HCMF") and (ii) 172,200 shares held by LAMP Hayman Capital Fund ("LAMP HCM"). Hayman Capital Management acts as an investment adviser to, and manages investment and trading accounts of, other persons, including HCMF. Hayman Capital Management may be deemed, through investment advisory contracts or otherwise, to beneficially own securities owned by other persons, including HCMF. Hayman Investments is the general partner of Hayman Capital Management and, in such capacity, may be deemed to control Hayman Capital Management and beneficially own securities beneficially owned by Hayman Capital Management. Mr. Bass is the managing member of Hayman Investments and, in such capacity, may be deemed to control Hayman Investments and beneficially own securities beneficially owned by Hayman Investments. Mr. Osmon is a managing director of Hayman Capital Management and is a director of the Company. Securities of the Company held by Mr. Osmon may be deemed to be beneficially owned by HCMF. All other securities of the Company reported herein are held for the account of HCMF.
|
|
(5)
|
Represents 10,000 shares held in the Susan A. Ozanne Trust of which Mr. Ozanne and his wife are co-trustees and beneficiaries, 10,000 shares held in the James H. Ozanne Revocable Trust of which Mr. Ozanne is the sole trustee and beneficiary, 17,390 vested RSUs, 37,813 vested stock options, 35,877 RSUs expected to vest within 60 days of March 26, 2015 and 37,812 stock options expected to vest within 60 days of March 26, 2015.
|
|
(6)
|
Represents 10,000 shares held in the Scheid Family Trust of which Mr. Scheid and his wife are co-trustees and beneficiaries, 34,890 vested RSUs, 37,813 vested stock options, 35,877 RSUs expected to vest within 60 days of March 26, 2015 and 37,812 stock options expected to vest within 60 days of March 26, 2015.
|
|
(7)
|
Represents 19,422 vested RSUs, 18,907 vested stock options and 4,940 RSUs expected to vest within 60 days of March 26, 2015.
|
|
(8)
|
Represents 45,000 shares held in the James G. Jones and Maria F. Jones Revocable Trust of which Mr. Jones and his wife are co-trustees and beneficiaries, 19,422 vested RSUs, 18,907 vested stock options and 4,940 RSUs expected to vest within 60 days of March 26, 2015.
|
|
(9)
|
Represents 3,952 vested RSUs, 18,907 vested stock options and 4,940 RSUs expected to vest within 60 days of March 26, 2015.
|
|
Greater than 5% Stockholders, as of March 26, 2015
|
Number
|
%
|
|
Claren Road Asset Management, LLC
(1)
|
6,000,000
|
10.25%
|
|
Hayman Capital Management, L.P.
(2)
|
5,496,500
|
9.39%
|
|
Amici Capital, LLC
(3)
|
4,743,165
|
8.11%
|
|
Oaktree Capital Management LP
(4)
|
3,422,674
|
5.85%
|
|
CI Investments Inc.
(5)
|
3,262,815
|
5.58%
|
|
(1)
|
Based on a Form 4 filed with the SEC on February 6, 2015 and Schedule 13G filed with the SEC on February 11, 2014. Claren Road Asset Management, LLC ("Claren Road") reports that these securities are held by Claren Road Credit Opportunities Master Fund, Ltd. ("Credit Opportunities Fund") and Claren Road Credit Master Fund, Ltd ("Credit Master Fund"). Claren Road and the Credit Master Fund beneficially own these shares and share voting and dispositive power. Claren Road serves as investment manager for the Credit Opportunities Fund and Credit Master Fund. Day to day management of Claren Road including investment and voting decisions have been delegated to Messrs. Brian Riano, Sean Fahey, John Eckerson and Albert Marino, members of Claren Road. Claren Road disclaims beneficial ownership of these shares. The address of Claren Road and the Funds is 900 Third Avenue, 29th Floor, New York, NY 10022.
|
|
(2)
|
Based on a Schedule 13D filed with the SEC on November 18, 2013. Hayman Capital Management, Hayman Investments and J. Kyle Bass report that they beneficially own 5,496,500 shares, with sole voting and dispositive power. Hayman Capital Management acts as an investment adviser to, and manages investment and trading accounts of, other persons, including HCMF. Hayman Capital Management may be deemed, through investment advisory contracts or otherwise, to beneficially own securities owned by other persons, including HCMF. Hayman Investments is the general partner of Hayman Capital Management and, in such capacity, may be deemed to control Hayman Capital Management and beneficially own securities beneficially owned by Hayman Capital Management. Mr. Bass is the managing member of Hayman Investments and, in such capacity, may be deemed to control Hayman Investments and beneficially own securities beneficially owned by Hayman Investments. Mr. Osmon is a managing director of Hayman Capital Management and is a director of the Company. Securities of the Company held by Mr. Osmon may be deemed to be beneficially owned by HCMF. All other securities of the Company reported herein are held for the account of HCMF. The address of the principal business office for Hayman Capital Management, HCMF, Hayman Investments and J. Kyle Bass is 2101 Cedar Springs Drive, Suite 1400, Dallas, Texas, 75201.
|
|
(3)
|
Based on a Schedule 13G filed with the SEC on February 17, 2015. Amici Capital, LLC (“Amici Capital”) reports that these shares are held by advisory clients. Paul E. Orlin is the managing member of Amici Capital. Amici Capital and Paul E. Orlin beneficially own these shares and share voting and dispositive power. The address of the principal business office for Amici Capital, LLC and Paul E. Orlin is 666 5th Avenue, Suite 3403, New York, New York 10103.
|
|
(4)
|
Based on a Schedule 13G filed with the SEC on March 2, 2015. The number of shares reported includes: a) 3,288,223 shares over which Oaktree Value Equity Holdings, L.P. (“VE Holdings") has sole voting and dispositive power; and (b) 134,451 shares over which Oaktree Value Equity Fund-SP, L.P. (“VEF-SP") has sole voting and dispositive power. The general partner of VE Holdings is Oaktree Value Equity Fund GP, L.P. (“VEF GP"). The general partner of VEF GP is Oaktree Value Equity Fund GP Ltd (“VEF Ltd."). The General partner of VEF-SP is Oaktree Value Equity Fund-SP GP, L.P. (“VEF-SP GP"). The sole director of VEF Ltd. and the general partner of VEF-SP GP is Oaktree Capital Management, L.P. (“Management”). The general partner of Management is Oaktree Holdings, Inc. ("Holdings"). The sole shareholder of VEF Ltd. is Oaktree Fund GP I, L.P. (“GP I"). The general partner of GP I is Oaktree Capital I, L.P. (“Capital I"). The general partner of Capital I is OCM Holdings I, LLC (“Holdings I"). The managing member of Holdings I is Oaktree Holdings, LLC (“Holdings LLC"). The sole shareholder of Holdings and the managing member of Holdings LLC is Oaktree Capital Group, LLC, (“OCG"). The duly elected manager of OCG is Oaktree Capital Group Holdings GP, LLC. The address of the principal business office for the above entities is 333 S. Grand Avenue, 28th Floor, Los Angeles, CA 90071.
|
|
(5)
|
Based on a Schedule 13G filed with the SEC on February 12, 2015. CI Investments Inc. reports that it and Signature Global Asset Management, an internal business unit of CI Investments Inc., beneficially own these shares and share voting and dispositive power. The address of CI Investments Inc. is 2 Queen Street East, 20th Floor, Toronto, Ontario, Canada, M5C 3G7.
|
|
Plan Category
|
Number of securities to be issued upon exercise of outstanding options, warrants, and rights (2)
|
Weighted-average exercise price of outstanding options, warrants, and rights (3)
|
Number of securities remaining available for future issuance under equity compensation plans (4)
|
||||
|
Equity compensation plans approved by security holders (1)
|
4,839,317
|
|
10.66
|
|
4,148,350
|
|
|
|
Equity compensation plans not approved by security holders
|
—
|
|
—
|
|
—
|
|
|
|
Total
|
4,839,317
|
|
$
|
10.66
|
|
4,148,350
|
|
|
(1)
|
NMI 2012 Stock Incentive Plan ("2012 Plan") and NMI 2014 Omnibus Incentive Plan ("2014 Plan").
|
|
(2)
|
Includes 3,630,139 shares to be issued upon exercise of outstanding stock options under the 2012 Plan and 1,209,178 shares of unvested RSUs granted under the 2012 Plan.
|
|
(3)
|
Weighted-average exercise price is based solely on outstanding options.
|
|
(4)
|
The amount shown represents 148,350 shares reserved for issuance under the 2012 Plan and 4,000,000 shares reserved for issuance under the 2014 Plan.
|
|
|
2014
|
|
2013
|
||||
|
Audit Fees
|
$
|
518,883
|
|
|
$
|
692,324
|
|
|
Audit-Related Fees
|
—
|
|
|
9,000
|
|
||
|
Tax Fees
|
—
|
|
|
7,315
|
|
||
|
All Other Fees
|
—
|
|
|
—
|
|
||
|
Total Fees
|
$
|
518,883
|
|
|
$
|
708,639
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|